Skip to content
Review

A-005 Differentiation of Myocardial Injury Etiologies Using the Long-T ITC Complex: First U.S. Report from the MERITnI Study

Oct 2026 · Clinical Chemistry · Vol 72 · 0 citations

TL;DR

Long-T ITC concentrations and the long-T ITC/hs-cTnT specific ratio can statistically differentiate type 1 myocardial infarction and acute non-MI myocardial injury from chronic myocardial injury based on the initial 0-hour blood draw at time of presentation.

Abstract

Early and accurate differentiation of acute myocardial infarction (MI) from non-ischemic and chronic myocardial injury remains a diagnostic challenge in patients presenting with suspected acute coronary syndrome (ACS). While high-sensitivity cardiac troponin (hs-cTn) assays enable earlier detection of myocardial injury, additional biomarkers that reflect early release kinetics may improve discrimination between acute and chronic processes. Data on circulating long-T ITC complex concentrations in this setting are limited. We evaluated the early release profile of long-T ITC complex in comparison with hs-cTnT and hs-cTnI in patients presenting to the emergency department (ED) with suspected ACS. We analyzed consecutive patients enrolled in the Mindray hs-cTnI Assay Analytical and Clinical Evaluation for the Diagnosis and Risk Assessment of Myocardial Infarction (MERITnI; NCT05853042) trial who presented to the ED with suspected ACS. Lithium heparin plasma samples obtained at 0- and 2-hours were tested on the Mindray CL-1200i platform chemiluminescence immunoassay for long-T ITC complex, hs-cTnT, and hs-cTnI. Absolute concentrations and biomarker ratios (long-T ITC/hs-cTnT) were assessed. All patients were adjudicated by predetermined clinicians for MI or no MI according to the 4th universal definition of MI after review of all available medical records, including 12-lead ECG, echocardiography, angiography, Alinity hs-cTnI concentrations, and clinical presentation. Among 882 subjects, 47 (5.3%) had acute MI, including 2.7% type 1 MI and 2.7% type 2 MI, and 23.4% had non-MI injury. Median time from symptom onset to presentation was 3.0 hours. Long-T ITC complex concentrations were higher patients with type1 MI, acute non-MI injury and chronic myocardial injury compared to patients without myocardial injury. Patients with type 1 MI demonstrated significantly higher long-T ITC concentrations compared with those with non-MI myocardial injury. The long-T ITC/hs-cTnI ratio increased significantly between 0 and 2 hours in patients with type 1 MI and acute non-MI injury, but not in chronic injury. This finding suggests a more rapid early release of long-T ITC complex compared with hs-cTnT in early serial sampling. Neither absolute concentrations nor ratios distinguished type 1 MI from type 2 MI. Long-T ITC concentrations and the long-T ITC/hs-cTnT specific ratio can statistically differentiate type 1 myocardial infarction and acute non-MI myocardial injury from chronic myocardial injury based on the initial 0-hour blood draw at time of presentation.

View source

Similar papers

Sep 2026

Rapid myocardial infarction rule-out: A single high-sensitivity cardiac troponin I and T threshold strategy for the Chinese emergency department.

BACKGROUND High-sensitivity cardiac troponin (hs-cTn) discerns MI with high sensitivity, facilitating swift ED discharge. Yet, its application in Chinese cohorts is understudied. This study seeks optimal hs-cTnI and hs-cTnT thresholds for low-risk patient identification in Chinese EDs, utilizing Abbott and Roche assays...

Fang-Fang Yang, Ya-Hui Lin, Hong Zhan et al. · 0 citations
Oct 2026

A-026 Impact of Chronic Kidney Disease on the Diagnostic Performance of the 0/1-Hour High-Sensitivity Cardiac Troponin T Triage Algorithm

The 0/1-hour triage algorithm using high-sensitivity cardiac troponin (hs-cTn) is recommended for rapid rule-out and rule-in of myocardial infarction (MI). However, its performance in patients with chronic kidney disease (CKD), who often have chronically elevated troponin remains less certain in US populations. O...

A. Muthukumar · 0 citations
Open access Aug 2026

Evaluation of risk stratification at presentation using the Alinity high-sensitivity cardiac troponin I assay

Background: High-sensitivity cardiac troponin (hs-cTn) assays enable safe early discharge of patients at very low risk for myocardial infarction. We previously developed a single-sample rule-out pathway using the ARCHITECT hs-cTnI assay to risk stratify patients with suspected acute coronary syndrome. In a secondary an...

Z. Li, T. Fujisawa, O. Skadberg et al. · 0 citations
Oct 2026

A-006 Diagnostic performance of an investigational high-sensitivity cardiac troponin T and long-T ITC troponin complex assays for acute myocardial infarction in females and males

Assessment of the diagnostic performance of an investigational Mindray CL-1200i hs-cTnT chemiluminescence immunoassay for type 1 MI and type 2 MI compared to standard of care Abbott Alinity hs-cTnI assay and investigational Mindray hs-cTnI assay investigated whether the long-T ITC complex assay can provide additional d...

Joshua R. Miller, Y. Sandoval, Stephen W. Smith et al. · 0 citations
Oct 2026

A-023 Evaluation of Interfering Substances in VITROS High-Sensitivity Cardiac Troponin I Assay

Cardiac troponin is established as the primary and core biomarker for the diagnosis of myocardial infarction in the Fourth Universal Definition of Myocardial Infarction. Specifically, high-sensitivity cardiac troponin I (hs-cTnI) acts as a key indicator in diagnosing acute myocardial injury such as acute myocardi...

Dong-Yang Li, Yan Wu, Ying Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.